BTAI
BTAI
NASDAQ · Biotechnology

Bioxcel Therapeutics Inc

$0.04
-0.02 (-27.48%)
As of Sep 28, 10:33 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +49,137.7% upside
Low Target $14.05
Average Target $21.96
High Target $26.87
Current Price $0.04
Current
$0.04
Target
$21.96
$14.05 $21.96 avg $26.87
Scenario Analysis
Bear Case
$14.05
31,402.2%
Low target
Base Case
$21.96
+49,137.7%
Avg target
Bull Case
$26.87
+60,146.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
Target vs 52W High
$21.96
+641.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%